| |
| | [No title] (Site not responding. Last check: 2007-11-04) |
 | | Moreover, the bioavailability of each vitamin and mineral in a multi-vitamin formulation is affected by the presence of other vitamins and minerals in the formulation, as well as by the amounts of each vitamin and mineral present and the physiological state of the individual using said formulation. |
 | | Non-limiting exemplary vitamin deficiencies include vitamin A deficiency, hypervitaminosis A, vitamin D deficiency and dependancy, hypervitaminosis D, vitamin E deficiency and toxicity, vitamin K deficiency, hypervitaminosis K, essential fatty acid deficiency, thiamine deficiency, riboflavin deficiency, niacin deficiency, vitamin B6 deficiency and dependency, biotin deficiency and dependancy, pantothenic acid deficiency, carnitine deficiency and vitamin C deficiency. |
 | | The method of claim 26, wherein the vitamins and minerals are selected from the group consisting of a pharmaceutically acceptable calcium compound, vitamin D, vitamin A, B complex vitamins, vitamin E, a pharmaceutically acceptable iron compound, a pharmaceutically acceptable zinc compound and mixtures thereof. |
| www.wipo.int /cgi-pct/guest/getbykey5?KEY=00/07463.000217&ELEMENT_SET=DECL (7142 words) |
|